Transcatheter Closure Of Patent Ductus Arteriosus In Selçuk University

This study was aimed to evaluate our clinical experience and results of transcatheter closure of patent ductus arteriosus patients in our clinic between June 2011 and November 2013. Atotal of 21 patients (16 female, 5 male) undergoing transcatheter patent ductus arteriosus closure procedure with mean age 5.4 (9 months and-17 years-old) were included in this study retrospectively. Transcatheter patent ductus arteriosus closure procedure was successfully performed in 21 patients (100%) without any complication like device erosion, arrythmia, thrombosis or residual shunt during follow-up. Amplatzer ductal occluder 1 device was used in 11 patients, Amplatzer ductal occluder 2 device was used in 9 patients and MemoPart PDA Occluder device was used in one patient. Percutaneous closure of patent ductus arteriosus defects with occlusive devices is safe and effective procedure with a high success rate and less complications.